Добавил:
Upload Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
хронический панкреатит.doc
Скачиваний:
30
Добавлен:
15.09.2019
Размер:
10.5 Mб
Скачать

432 • Хронический панкреатит

  1. Skiff J. I., Wolfe M. M., Toskes P. P. Elevated fasting cholecystokinin levels in pancreatic exocrine impairment: evidence to support feedback regulation // J. Lab. Gin. Med.— 1985.—Vol.105.-P.282.

  2. Smits M. £., Badiga S. M., Rauws E. A. J. et al. Long-term results of pancreatic stems in chronic pancreatitis // Gastrointest. Endosc— 1995.— Vol.42.— P.461.

  3. Smyth R. L., Ashby D., O'Hea U., Burrows E., Lewis P., van Vefcen D., Dodge J. A. Fibros- ing colonopathy in cystic fibrosis: results of a case-control study // Lancet.— 1995.— Vol. 346 (11).—P.1247—1251.

  4. Spannagel A. W., Green G. M., Guan D. et al. Purification and characterization of a luminal CCK-releasing factor from rat intestinal secretion // Proc. Natl. Acad. Sci. USA — 1996.— Vol.93.-P.4415.

  5. Spicak A., Hubaczova M., Antos F. et al. The role of antibiotic treatment in sever form jf acute pancreatitis : A randomized prospective study // J. Gastroent. Hepatol.— 2002.— Vol.17 (Suppl.).-P.499.

  6. Srinathan S. K., Barkun S., Mehta, S. N. et al. Evolving management of mild-to-moderate gallstone pancreatitis // J. Gastrointest. Surg.— 1998.— Vol.2.— P.385—390.

  7. Stevens J. C, Maguiness K. M., Hollingsworth J., Heilman D. K., Chong S. K. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy / / J. Pediatr. Gastroenterol. Nutr.- 1998.- Vol. 26 (I).- P.80-84.

  8. Su S. В., Motoo Y., Xie M. J. et al. Expression of transforming growth factor-beta in spon- taneus chronic pancreatitis in the WBN/Kob rat // Dig. Dis. Sci.— 2000.— Vol. 45 (J).— P.J51-159.

  9. Sugermon H. J., Bamhart G. R., Newsome N. H. Selective drainage for pancreatic, biliary and duodenal obstruction secondary to chronic fibrosing pancreatitis // Ann. Surg.— 1986.- Vol.203.- P.558-567.

  10. Suzuki A., Mizumoto A., Rerknimitr R. et al. Effect of bacterial or porcrine lipase with low- or high-fat diets on nutrient absorption in pancreatic-insufficient dogs // Gastroenterol.— 1999.—Vol. 116 (2).—P.431-437.

41 J. Szabo S., Usadel К. Н. Cytoprotection-organoprotection by somatostatin: gastric and he­patic lesions // Experientia,— 1982.— Vol.38.— P.254.

4J2. Taylor R. H., Bagley F. H., Braash J. W., Warren K. W. Ductal drainage or persection for chronic pancreatitis // Am. J. Surg.—1981,—Vol.141.—P.28—33.

413. Thiruvengadam R., DiMagno E. P. Inactivation of human lipase by proteases // Am. J. Physiol.- 1988.— Vol.255.— P.476-481.

4J4. Thompson S. R., Hendry W. S., McFarlane G. A., Davidson A. 1. Epidemiology and out­come of acute pancreatitis // Br. J. Surg.— 1987.— Vol.74.— P.398—401.

  1. Toh S. K. C, Phillips S., Johnson С D. A prospective audit against national standards of the presentation and management of acute pancreatitis in the South of England // Gut.— 2000.- Vol.46.- P.239-243.

  2. Toouli J., Brooke-Smith M., Bassi С et al. Guidelines for the managtmtnt of acute pancre­ atitis // J. Gastroenterol. Hepatol.— 2002,— Vol.17 (Suppl.).— P.15—19.

  3. Toskes P. P. Medical therapy of chronic pancreatitis // Semin. Gastrointest. Dis.— 1991.— Vol.2.—P.188.

  4. Toskes P. P., Forsmark С E., DeMeo M. T. et al. A multicenter controlled trial of octre- otide for the pain of chronic pancreatitis // Pancreas.— 1993.— Vol. 8 (6).— P.774.

  5. Tran Т. М. et al. Effects of a proton pomp inhibitor in cistic fibrosis // Acta Pediatr.— 1998.- Vol.87.- P.553-558.

  6. Trapnell J. E. Chronic relapsing pancreatitis: a review of 64 cases // Br. J. Surg.— 1979.— Vol.66.-P.471.

  7. Travaso L. W., Longmire W. P. Preserving of the pylorus in pancreaticoduodenectomy // Surg. Gynecol. Obstet.- 1978.- Vol.146.- P.959.

  8. Ukita Т., SeikeM., Ikeda M. et al. Pancreatic stenting in chronic pancreatitis with stricture and/or pancreatolithiasis // Gut.— 2003,- Vol.52 (Suppl. VI).- P.83.

  9. Ulrich C. D. Novel applications of somatostatin analogues in gastroenterology. Pancreatitis: clinical evidence defining benefis // Postgraduate institute for medicine, 2002.

  10. Uomo G. Pancreatic head mass: How can we treat it? Acute pancreatitis: conservative treat­ ment//JOP. J. Pancreas (Online).—2000,—Vol.1 (Suppl. 3).— P.130—137.

  11. Usadel К. В., Kessler H., Rohr G. et al Cytoprotective properties of somatostatins // Klin. Wochenschr,— 1986.- Vol.64 (Suppl. 7).- P.59.

  12. Van Outryve M., Mayeur S., Meeus M. A. et al. A double-blind crossover comparison study of the safety and efficacy of mebeverine with mebeverine sustained release in the treatment if irritable bowel syndrome // J. Clin. Pharm. Then— 1995.— Vol.20.— P.277—278.